[28-14-am] Drug Design 3, Other

4:59 PM - 5:11 PM JST(7:59 AM - 8:11 AM UTC)

[28-14-pm18S] Development of 4'-thiomodified siRNAs as anti-SARS-CoV-2 agents

○Yuhei Nogi¹, Rina Ozaki¹, Noriko Saito Tarashima¹, Takaaki Koma², Jun Tsukimoto¹, Masako Nomaguchi², Noriaki Minakawa¹ (1. Grad. Sch. Pharm. Sci., Tokushima Univ., 2. Grad. Sch. Med., Tokushima Univ.)